Skip to main content
Published locations for Sorafenib plus HAIC a favorable therapeutic option for HCC with major portal vein tumor thrombosis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Sorafenib plus HAIC a favorable therapeutic option for HCC with major portal vein tumor thrombosis
User login
Username
Password
Reset your password
/content/sorafenib-plus-haic-favorable-therapeutic-option-hcc-major-portal-vein-tumor-thrombosis
/fedprac/article/252040/hepatocellular-carcinoma/sorafenib-plus-haic-favorable-therapeutic-option-hcc